P1169 EFFECT OF PEGYLATED INTERFERON OR RIBAVIRIN DOSE REDUCTION DURING TELAPREVIR BASED THERAPY ON SVR12 IN NULL-RESPONDERS AND RELAPSERS WITH ADVANCED LIVER FIBROSIS (ADVEX STUDY)

Autor: Zarebska-Michaluk, D., Flisiak, R., Janczewska, E., Berak, H., Dobracka, B., Librant-Suska, M., Kozielewicz, D., Lojewski, W., Jurczyk, K., Lapinski, T., Musialik, J., Postawa-Klosinska, B., Wroblewski, J., Augustyniak, K., Dudziak, M., Olszok, I., Ruszala, A., Kryczka, W., Pisula, A., Horban, A., Dobracki, W.
Zdroj: In Journal of Hepatology April 2014 60(1) Supplement:S474-S474
Databáze: ScienceDirect